METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT
United Kingdom
17805342.7
Filed on 2019-05-06
17805342.7
Filed on 2019-05-06
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT
Germany
17805342.7
Filed on 2019-05-06
17805342.7
Filed on 2019-05-06
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT
France
17805342.7
Filed on 2019-05-06
17805342.7
Filed on 2019-05-06
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS
US Application 17/692,787
Filed on 2022-03-11
Filed on 2022-03-11
CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer
Japan
2022-22792
Filed on 2022-02-17
2022-22792
Filed on 2022-02-17
A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA
US Application 17/766,015
Filed on 2022-04-01
Filed on 2022-04-01
A VIRAL EXPOSURE SIGNATURE FOR DETECTION OF EARLY STAGE HEPATOCELLULAR CARCINOMA
China
202080071446.7
Filed on 2020-10-09
202080071446.7
Filed on 2020-10-09
T CELL RECEPTORS RECOGNIZING HLA-A1-RESTRICTED MAGE-A3
US Application 17/691,569
Filed on 2022-03-10
Filed on 2022-03-10
Intracellular Genomic Transplant and Methods of Therapy
US Application 17/674,378
Filed on 2022-02-17
Filed on 2022-02-17
Intermittent Dosing Of Cediranib Alone Or In Combination With Durvalumab
US Application 16/077,720
Filed on 2018-08-13
Filed on 2018-08-13